Stifel, an investment firm, has maintained its hold rating on Norfolk Southern shares with a stock price target of $233 [fdbd4579]. The firm views the appointment of John Orr as the new executive vice president and chief operating officer (COO) as a potentially positive development in the ongoing proxy battle with Ancora Group [fdbd4579]. Stifel believes that bringing Orr on board could represent a step towards a resolution that may benefit the company in the long term [fdbd4579]. However, the firm's cautious approach suggests that the current stock valuation does not warrant an aggressive pursuit of the shares [fdbd4579].
TD Cowen has raised the share price target for Norfolk Southern Corporation to $253 from $236, citing operational optimism [a5f097cf]. The adjustment follows the hiring of John Orr as Chief Operating Officer and the company's revised second-half operating ratio guidance [a5f097cf]. TD Cowen expressed a positive outlook on these developments and reiterated its Market Perform rating for the stock [a5f097cf].
Jefferies has upgraded Southern Copper Corporation (SCCO) stock from Hold to Buy and increased the price target to $130.00, up from $91.00 [c94569e9]. The upgrade is based on the company's solid performance and promising outlook, with the de-risking of its development projects contributing to the raised target price [c94569e9]. The new sum-of-the-parts (SoTP) valuation for SCCO is $130, with around half of the increase attributed to reduced project risk [c94569e9]. Jefferies also noted that the valuation gap for SCCO's parent company, Grupo Mexico, has widened, but the focus remains on SCCO due to its expected benefits from higher copper prices, improved production volumes, and the potential launch of the Tia Maria project [c94569e9].
CFRA has upgraded their rating on Thermo Fisher Scientific shares from Hold to Buy and increased the price target to $635 from $522 [38df3152]. The new price target is based on CFRA's projected earnings per share (EPS) for 2025 and represents a significant increase [38df3152]. CFRA maintains a positive outlook on the company's long-term financial performance despite a downward revision of the EPS estimate for 2024 [38df3152]. The upgrade reflects CFRA's confidence in Thermo Fisher's growth prospects and their belief that the stock's valuation is justified [38df3152]. Investors may view this upgrade as a positive signal about the company's financial health and market position [38df3152].
TD Cowen has maintained its Hold rating on Raymond James shares and increased the price target from $126.00 to $130.00 [9a13cfad]. The decision came after Raymond James' stock price remained nearly unchanged following the company's Investor Day on Thursday, May 23, 2024 [9a13cfad]. The firm noted that Raymond James' strategic direction appeared to remain consistent even after recent leadership succession announcements, and financial guidance was reaffirmed [9a13cfad]. TD Cowen believes that the Investor Day did not prompt significant changes to the consensus-like fiscal years 2024-2025 adjusted EPS estimates [9a13cfad]. The price target adjustment to $130.00 reflects a modestly optimistic view of Raymond James' financial prospects [9a13cfad]. This update suggests that Raymond James is on a stable financial path, with leadership transitions and strategic decisions not significantly altering the company's forecasted earnings [9a13cfad].